login
login

Europe Daily Bulletin No. 7840

13 November 2000
Contents Publication in full By article 28 / 33
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

Germany's BASF has handed the sale of its pharmaceuticals subsidiary KNOLL to the American business bank WASSERSTEIN PERELLA. This sale should make the company at least 7 bn euro. BASF had a turnover in the pharmaceuticals sector of 2.5 bn euro in 1999. In addition, BASF and the Anglo-Dutch group ROYAL DUTCH SHELL are to rename ELLBA their 50/50 styrene and propylene-oxide joint-venture, so far named BASELL in Europe and Asia.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
WEEKLY SUPPLEMENTS